Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Change in Accured Expenses (2021 - 2025)

Tenon Medical (TNON) has 5 years of Change in Accured Expenses data on record, last reported at $499000.0 in Q3 2025.

  • For Q3 2025, Change in Accured Expenses rose 306.2% year-over-year to $499000.0; the TTM value through Sep 2025 reached $327000.0, up 161.6%, while the annual FY2024 figure was -$171000.0, 72.73% down from the prior year.
  • Change in Accured Expenses reached $499000.0 in Q3 2025 per TNON's latest filing, up from $55000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2022 and bottomed at -$1.1 million in Q3 2022.
  • Average Change in Accured Expenses over 5 years is $162368.4, with a median of $20000.0 recorded in 2021.
  • The widest YoY moves for Change in Accured Expenses: up 6600.0% in 2024, down 1644.44% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $258000.0 in 2021, then skyrocketed by 974.81% to $2.8 million in 2022, then crashed by 100.65% to -$18000.0 in 2023, then plummeted by 1644.44% to -$314000.0 in 2024, then soared by 258.92% to $499000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $499000.0 in Q3 2025, $55000.0 in Q2 2025, and $87000.0 in Q1 2025.